Literature DB >> 18086411

Inhibitors of HIV-1 reverse transcriptase.

Tatiana Ilina1, Michael A Parniak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18086411     DOI： 10.1016/S1054-3589(07)56005-9

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  10 in total

Review 1.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

2.  SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors.

Authors:  Andrew D Huber; Eleftherios Michailidis; Megan L Schultz; Yee T Ong; Nicolin Bloch; Maritza N Puray-Chavez; Maxwell D Leslie; Juan Ji; Anthony D Lucas; Karen A Kirby; Nathaniel R Landau; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  Determinants of Active-Site Inhibitor Interaction with HIV-1 RNase H.

Authors:  Zhaoyong Xi; Zhengqiang Wang; Stefan G Sarafianos; Nataliya S Myshakina; Rieko Ishima
Journal:  ACS Infect Dis       Date:  2019-10-02       Impact factor: 5.084

4.  Interaction of HIV-1 reverse transcriptase ribonuclease H with an acylhydrazone inhibitor.

Authors:  Qingguo Gong; Lakshmi Menon; Tatiana Ilina; Lena G Miller; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2010-11-29       Impact factor: 2.817

5.  Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer.

Authors:  Zhaoyong Xi; Tatiana V Ilina; Michel Guerrero; Lixin Fan; Nicolas Sluis-Cremer; Yun-Xing Wang; Rieko Ishima
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

Review 6.  Retroviral RNase H: Structure, mechanism, and inhibition.

Authors:  Tatiana V Ilina; Teresa Brosenitsch; Nicolas Sluis-Cremer; Rieko Ishima
Journal:  Enzymes       Date:  2021-09-24

7.  Structural basis of the allosteric inhibitor interaction on the HIV-1 reverse transcriptase RNase H domain.

Authors:  Martin T Christen; Lakshmi Menon; Nataliya S Myshakina; Jinwoo Ahn; Michael A Parniak; Rieko Ishima
Journal:  Chem Biol Drug Des       Date:  2012-08-31       Impact factor: 2.817

8.  Inhibitors of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity.

Authors:  Tatiana Ilina; Krystal Labarge; Stefan G Sarafianos; Rieko Ishima; Michael A Parniak
Journal:  Biology (Basel)       Date:  2012-10-19

9.  Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3'-azido-3'-deoxythymidine through both RNase H-dependent and -independent mechanisms.

Authors:  Maryam Ehteshami; Greg L Beilhartz; Brian J Scarth; Egor P Tchesnokov; Suzanne McCormick; Brian Wynhoven; P Richard Harrigan; Matthias Götte
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

10.  Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy.

Authors:  Sami Hussain Al Hajjar; Husn Frayha; Sahar Althawadi
Journal:  Ann Saudi Med       Date:  2012 Nov-Dec       Impact factor: 1.526
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.